Glaukos Corporation (GKOS)
USD 82.27
(-4.42%)
USD 82.27
(-4.42%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 290.27 Million USD | 10.39% |
| 2022 | 262.95 Million USD | -6.64% |
| 2021 | 281.66 Million USD | 61.68% |
| 2020 | 174.21 Million USD | 1607.98% |
| 2019 | 10.2 Million USD | 134.2% |
| 2018 | -29.82 Million USD | -21.68% |
| 2017 | -24.5 Million USD | -277.39% |
| 2016 | -6.49 Million USD | 45.32% |
| 2015 | -11.87 Million USD | -169.67% |
| 2014 | 17.04 Million USD | 58.24% |
| 2013 | 10.77 Million USD | 721.94% |
| 2012 | -1.73 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 88.53 Million USD | -74.04% |
| 2024 Q1 | 341.02 Million USD | 17.48% |
| 2024 Q3 | 56.98 Million USD | -35.64% |
| 2023 Q3 | 274.85 Million USD | -4.92% |
| 2023 Q1 | 306.84 Million USD | 16.69% |
| 2023 Q2 | 289.06 Million USD | -5.79% |
| 2023 Q4 | 290.27 Million USD | 5.61% |
| 2023 FY | 290.27 Million USD | 10.39% |
| 2022 Q4 | 262.95 Million USD | -5.58% |
| 2022 Q2 | 279.98 Million USD | 1.42% |
| 2022 Q3 | 278.48 Million USD | -0.54% |
| 2022 Q1 | 276.06 Million USD | -1.99% |
| 2022 FY | 262.95 Million USD | -6.64% |
| 2021 Q1 | 263.88 Million USD | 51.47% |
| 2021 FY | 281.66 Million USD | 61.68% |
| 2021 Q4 | 281.66 Million USD | 4.61% |
| 2021 Q3 | 269.24 Million USD | 5.97% |
| 2021 Q2 | 254.08 Million USD | -3.71% |
| 2020 Q3 | 185.11 Million USD | 2104.53% |
| 2020 Q4 | 174.21 Million USD | -5.89% |
| 2020 FY | 174.21 Million USD | 1607.98% |
| 2020 Q1 | 19.3 Million USD | 89.25% |
| 2020 Q2 | -9.23 Million USD | -147.84% |
| 2019 Q4 | 10.2 Million USD | -74.95% |
| 2019 Q1 | -21.5 Million USD | 27.88% |
| 2019 Q3 | 40.72 Million USD | 2.13% |
| 2019 Q2 | 39.87 Million USD | 285.41% |
| 2019 FY | 10.2 Million USD | 134.2% |
| 2018 Q1 | -15.58 Million USD | 36.4% |
| 2018 Q4 | -29.82 Million USD | 20.0% |
| 2018 Q3 | -37.27 Million USD | -49.46% |
| 2018 Q2 | -24.94 Million USD | -60.01% |
| 2018 FY | -29.82 Million USD | -21.68% |
| 2017 Q1 | -8.62 Million USD | -32.75% |
| 2017 FY | -24.5 Million USD | -277.39% |
| 2017 Q4 | -24.5 Million USD | -26.87% |
| 2017 Q3 | -19.31 Million USD | -44.49% |
| 2017 Q2 | -13.37 Million USD | -55.09% |
| 2016 Q4 | -6.49 Million USD | -233.2% |
| 2016 Q2 | -7.05 Million USD | -144.22% |
| 2016 Q1 | -2.88 Million USD | 75.68% |
| 2016 FY | -6.49 Million USD | 45.32% |
| 2016 Q3 | -1.94 Million USD | 72.37% |
| 2015 Q1 | 18.1 Million USD | 6.2% |
| 2015 Q2 | -83.21 Million USD | -559.68% |
| 2015 FY | -11.87 Million USD | -169.67% |
| 2015 Q4 | -11.87 Million USD | 85.42% |
| 2015 Q3 | -81.48 Million USD | 2.08% |
| 2014 Q1 | 14.38 Million USD | 33.55% |
| 2014 FY | 17.04 Million USD | 58.24% |
| 2014 Q4 | 17.04 Million USD | 0.0% |
| 2014 Q2 | 15.38 Million USD | 6.94% |
| 2013 FY | 10.77 Million USD | 721.94% |
| 2013 Q4 | 10.77 Million USD | 0.0% |
| 2013 Q3 | 10.77 Million USD | 0.0% |
| 2012 FY | -1.73 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Abbott Laboratories | 8.97 Billion USD | 96.767% |
| Allurion Technologies Inc. | 3.82 Million USD | -7498.717% |
| Artivion, Inc. | 300.4 Million USD | 3.372% |
| Avanos Medical, Inc. | 121.4 Million USD | -139.103% |
| Butterfly Network, Inc. | -109.6 Million USD | 364.824% |
| Butterfly Network, Inc. | -109.6 Million USD | 364.824% |
| Bio-Rad Laboratories, Inc. | 1 Billion USD | 71.029% |
| Boston Scientific Corporation | 8.62 Billion USD | 96.635% |
| CONMED Corporation | 966.95 Million USD | 69.981% |
| Edwards Lifesciences Corporation | -449.1 Million USD | 164.634% |
| Paragon 28, Inc. | 36.39 Million USD | -697.645% |
| Globus Medical, Inc. | 53.11 Million USD | -446.526% |
| Inspire Medical Systems, Inc. | -160.69 Million USD | 280.639% |
| Integer Holdings Corporation | 1.01 Billion USD | 71.466% |
| Medtronic plc | 24.76 Billion USD | 98.828% |
| Myomo, Inc. | -6.27 Million USD | 4729.519% |
| Nevro Corp. | 117.61 Million USD | -146.808% |
| Owlet, Inc. | -1.34 Million USD | 21745.877% |
| Penumbra, Inc. | 66.85 Million USD | -334.167% |
| Vicarious Surgical Inc. | -37.99 Million USD | 864.072% |
| Smith & Nephew plc | 2.78 Billion USD | 89.566% |
| Sonendo, Inc. | 26.34 Million USD | -1001.932% |
| STERIS plc | 3.17 Billion USD | 90.861% |
| Stryker Corporation | 10.02 Billion USD | 97.104% |
| Vapotherm, Inc. | 102.66 Million USD | -182.731% |
| Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | 94.797% |